| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |